Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00481039
Recruitment Status : Completed
First Posted : June 1, 2007
Last Update Posted : September 4, 2009
Sponsor:
Information provided by:
HaEmek Medical Center, Israel

Tracking Information
First Submitted Date May 31, 2007
First Posted Date June 1, 2007
Last Update Posted Date September 4, 2009
Study Start Date May 2007
Actual Primary Completion Date December 2008   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures Not Provided
Original Primary Outcome Measures Not Provided
Change History Complete list of historical versions of study NCT00481039 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel
Official Title Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel- An Observational Study
Brief Summary

Sickle cell anemia and sickle cell thalassemia are frequent diseases among the israeli arab population. The purpose of this study is to assess the clinical characteristics of the patients in one arab village and the laboratory characteristics in the carriers of this gene based in the screening for pregnant women that is carried out in the population of northern Israel.

The results can be useful in order to institute universal screening for sickle cell anemia in northern Israel.

Detailed Description Not Provided
Study Type Observational
Study Design Observational Model: Case-Only
Time Perspective: Retrospective
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population All the patients diagnosed with abnormal hemoglobin in the bedouin arab village
Condition Sickle Cell Disease
Intervention Procedure: Medical history and basic laboratory analysis
Medical history and basic laboratory analysis
Study Groups/Cohorts 1
Patients diagnosed as having abnormal hemoglobin like hemoglobin S and thalassemia in a bedouin village
Intervention: Procedure: Medical history and basic laboratory analysis
Publications * Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Completed
Estimated Enrollment
 (submitted: September¬†3,¬†2009)
300
Original Enrollment Not Provided
Actual Study Completion Date December 2008
Actual Primary Completion Date December 2008   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • All the patients that were diagnosed as having sickle cell disease in the specific village and all the population screened for hemoglobinopathies in the same location
Sex/Gender
Sexes Eligible for Study: All
Ages Child, Adult, Older Adult
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Israel
Removed Location Countries  
 
Administrative Information
NCT Number NCT00481039
Other Study ID Numbers 5311006.EMC
Has Data Monitoring Committee No
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party Dr Koren Ariel, Pediatric Hematology Unit - Ha'Emek Medical Center
Study Sponsor HaEmek Medical Center, Israel
Collaborators Not Provided
Investigators
Study Director: Ariel Koren, MD Pediatric Hematology Unit, Ha'Emek Medical Center
Study Chair: luci Zalman, Phd Hematology Laboratory - HaEmek Medical Center
Principal Investigator: Tania Flaishman, Student Pediatric Dpt B - Ha'Emek Medical Center
PRS Account HaEmek Medical Center, Israel
Verification Date September 2009